EXOZYMES INC. (EXOZ)

↓ Download CSV

CIK 0002010788 · Nasdaq · Biological Products, (No Diagnostic Substances)

  • Sector Manufacturing
  • Incorporated NV
  • Fiscal year ends Dec 31

Key ratios (FY2025)

-269.6%
Return on equity
Metric (FY)2025202420232022
Revenue$70.1K
Operating Income-$9.72M-$5.93M-$1.80M
Net Income-$9.16M-$5.86M-$2.04M
EPS (Diluted)$-1.09$-0.89$-0.33
Total Assets$5.97M$13.03M$3.56M
Total Liabilities$2.57M$2.61M$3.94M
Shareholders' Equity$3.40M$10.42M-$384.3K$1.37M
Cash & Equivalents$3.04M$9.72M$66.5K
Operating Cash Flow-$6.50M-$8.51M-$1.18M
Capital Expenditures$169.9K$396.5K$288.7K
Shares Outstanding8.41M8.37M6.25M